RockstarMarkets
All news
Markets · Narrative··Updated 1h ago
Part of: Semiconductor Cycle

ARM Rallies 15% to $256.59 But Vera Royalties Capped at $400M vs. 100x Forward P/E

Analysts peg peak annual Vera CPU royalties for ARM at $150M to $400M, a figure that cannot justify a 100x forward P/E when NVDA itself trades at 33x on $91B guidance. Short-squeeze dynamics are inflating ARM well beyond fundamental support, with a valuation gap implying 10x to 25x overpricing relative to NVDA on the s

R
Rocky · RockstarMarkets desk
Synthesised from 8 wires · 46 mentions in the last 24h
Sentiment
+20
Momentum
60
Mentions · 24h
46
Articles · 24h
113
Affected sectors
Related markets

Key facts

  • ARM rallied 15% to $256.59 following NVDA $91B Q2 guidance
  • Analysts cap annual Vera royalties at $150M-$400M, yet ARM trades at 100x forward P/E
  • NVDA guides $20B standalone Vera CPU revenue; ARM collects royalties, not primary revenue
  • ARM's 100x forward P/E implies 10x-25x overvaluation vs. NVDA's 33x on Vera upside alone
  • Short-squeeze and volatility trading inflating ARM valuation beyond fundamental support

What's happening

ARM Holdings surged 15% on Friday, closing at $256.59, as markets attempted to reprice the company's exposure to Nvidia's Vera CPU opportunity. The narrative is seductive: Nvidia guides $91B for next quarter; Nvidia CEO Jensen Huang hinted at Vera capturing a meaningful slice of that $20B in standalone CPU revenue; ARM collects royalties on every Vera chip sold. Ergo, ARM is a pure-play leveraged bet on Vera adoption.

The math, however, does not hold. Analysts have capped annual Vera royalty revenue at between $150M and $400M, even under optimistic adoption scenarios. At the high end, that is $400M in annual revenue to ARM. ARM currently trades near a 100x forward P/E, implying the market is pricing in massive Vera upside that analyst bases simply do not support. Compare that to NVDA at 33x forward P/E and generating $91B in guidance, and the valuation gap becomes untenable.

The core issue is that Vera is not cannibalizing as much NVDA revenue as the market feared; Nvidia is selling it alongside its GPU franchise, not instead of it. ARM, meanwhile, is positioned as a toll collector rather than a primary beneficiary. The company's royalty structure caps its exposure. Even if Vera becomes a $5B annual business for Nvidia, ARM might see only $200M-$500M in royalties, a meaningful but not transformational contribution to a company that trades at $256.

Market participants are conflating visibility (Vera is real, Nvidia is investing heavily) with valuation (100x P/E is justified). ARM has legitimate growth drivers in data center and mobile, but the Vera royalty bid is a classic misdirected trade. The stock may hold above $300 on momentum and short-squeeze dynamics, but fundamental value is likely $180-$220. NVDA's beat did not validate ARM's repricing; it merely provided the volatility for ARM shorts to cover.

What to watch next

  • 01NVDA Vera CPU adoption rates: customer wins and attach rates in coming quarters
  • 02ARM licensing wins: non-Vera data-center and mobile deals to validate core thesis
  • 03ARM valuation reset: gap closure between current 100x P/E and justified 30x-50x range
Mention velocity · last 24 hours
Coverage from these sources
Previously on this story

Related coverage

More about $ARM

Topic hub
Semiconductor Cycle: AI Capex, Memory and the SOX Trade

Live coverage of the AI semiconductor cycle — NVDA, AVGO, AMD, ASML, memory demand, capex run rates and overbought signals.